INTRODUCTION
Cytochrome b561 is present in the membranes of chromaffin granules and other neuroendocrine secretory vesicles (Flatmark and Terland, 1971 ). This cytochrome functions as a unique transmembrane electron transfer protein by mediating the transfer of electrons from a soluble cytoplasmic donor (ascorbate) across a membrane bilayer to a soluble intravesicular acceptor (semidehydroascorbate) (Njus et al., 1983; Srivastava et al., 1984; Wakefield et al., 1986b) . This transmembrane electron transfer activity effectively regenerates the ascorbic acid inside neuroendocrine secretory vesicles, thereby providing reducing equivalents for intravesicular dopamine /J-hydroxylase and peptidyl a-amidating mono-oxygenase (Beers et al., 1986; Menniti et al., 1986; Wakefield et al., 1986a; Kent and Fleming, 1987; Dhariwal et al., 1989) . Thus cytochrome b561 acts as a transmembrane electron carrier which catalyses a long-range electron transfer between two cellular compartments. This long-range electron transfer is an integral part of most neuroendocrine secretory vesicle membranes and it is necessary to understand the structure and function of cytochrome b561 in order to investigate this process in detail. The primary structure of bovine cytochrome b561 has been predicted from cDNA to be 273 residues in length and a model has been proposed in which the polypeptide spans the membrane six times and contains little extramembranous sequence. Since the cytochrome does not contain a cleavable signal peptide, this model predicts an orientation of the protein in which both the N-terminus and Cterminus would be localized to the cytoplasmic side of the secretory vesicle membrane (N,Yt-C,Y) (Perin et al., 1988 ).
However, although topological studies have demonstrated that the C-terminus is exposed to the cytoplasmic side of the secretory vesicle membrane, the N-terminus is not facing the cytoplasmic side as it is unavailable to antibodies or proteases on that side of the membrane (Kent and Fleming, 1990) . Thus the proposed model is not completely supported by the available experimental evidence. cDNA. This smaller version of cytochrome b561 may contain only five transmembrane segments rather than the previously proposed six segments. The new model is in agreement with our previous results on transmembrane topology of the gene product. Northern-blot analysis shows an expanded tissue distribution of cytochrome mRNA expression where previous immunological assays were negative. These results support the hypothesis that cytochrome b561 is a marker for peptidergic and adrenergic tissues.
With regards to its function, cytochrome b561 fulfils the important role of regenerating intravesicular ascorbate for use by the vesicular mono-oxygenases. Therefore, it has been proposed that cytochrome b5,, may be a marker for neuroendocrine secretory vesicles (Perin et al., 1988 1618-1748, 3' non-coding region shown in Figure 2b ; 2623-2629, the adenylation site.
(199-171, see Figure 1 : 5'-ACAGCCGCCCCTGCTAGAT-GCGCGCAACA-3'). The oligonucleotides were end-labelled with 32P, hybridized to 50 S g of human brain total RNA (Clonetech) and extended using murine-leukaemia-virus reverse transcriptase (MLV-RT, Gibco-BRL) for h at 42 'C. Yeast tRNA was used as a negative control. The primer-extended products were separated on an 8 M urea/6 % polyacrylamide gel and then visualized by autoradiography.
Reverse transcription-PCR (RT-PCR)
The RT -PCRs we reperformed with human brain total RN A according to the manufacturer's instructions (Perkin-Elmer Cetus). MLV-RT was used to synthesize the first-strand cDNA using the specific antisense oligonucleotide, (593-570, see Figure 1 ): 5'-GAAGATCAGGCCTATGAC-CATGCA-3'. The product was subjected to PCR using one of the following sense primers: HCSP-1: 5'-GAGAGCGAGCG-CTGCTTCCAGCGGGAG-3' (intron sequence from the genomic clone); HCSP-4 (255-273, see Figure 1 ): 5'-GCGGC-TGTGCGCATCTTGA-3'; or HCSP-5 (171-189, see Figure 1 ): 5'-TGTTGCGCGCATCTAGCAG-3'. (Barlett and Smith, 1974 ). An aliquot of each membrane fraction was dissolved in sample buffer and separated by electrophoresis in an SDS/ 12% polyacrylamide gel under reducing conditions (Laemmli, 1970) . Separated proteins were then transblotted on to nitrocellulose. The blot was reacted with rabbit anti-(bovine cytochrome b561) serum and detected with anti-(rabbit IgG) antibody coupled to horseradish peroxidase (Vector Laboratories). The rabbit anti-(bovine cytochrome b560) was the same as previously described .
RESULTS
Cloning the human cytochrome b5,N 6.5 kb Xbal genomic fragment from one clone which hybridized was selected for subcloning and sequencing. Examination of the sequences upstream from the region complementary to the 5' end of HCR a revealed the presence of a translation initiation codon sequence.
Analysis of human cytochrome b5.1 sequence The sequence information derived from cDNA clones and genomic DNA clones, together with the deduced amino acid sequence, of human cytochrome b561 is shown in Figure 1 (Kozak, 1986 ).
The 5' untranslated region of the human cytochrome b5,1 mRNA is 404 bases in length. As shown in Figure 2(a) , comparison of this region with the corresponding region in the bovine cDNA reveals little sequence similarity. In order to ensure that 5' upstream sequences derived from the genomic clone are present in mRNA, we performed primer extension to assess the size of the mRNA transcript and RT-PCR to obtain the sequence for this region directly from mRNA. Primer extension was carried out using the primer HCASP-I which is downstream from ATG and another primer HCASP-2 which is in the 5' untranslated region. The former produced a primer extended product of approx. 460 bp (Figure 3a) and the latter produced two major products of approx. 199 and 191 bp with evidence of two other products of similar size (Figure 3b) . The major transcription start sites were therefore assigned to the cytosine residues 405 bp and 397 bp upstream from the translation initiation codon (nucleotides I and 8 respectively, see Figure 1 ). The negative control with yeast tRNA did not give any signal with these two primers.
To confirm further that the 5' sequences were not derived from introns, we performed RT-PCR of the human cytochrome b561
RNA. Total RNA from human brain was reverse transcribed into the first-strand cDNA using the antisense 3' primer, HCASP-191. The reaction was then subjected to PCR using the same 3' antisense primer and one of two 5' sense primers: HCSP-4 or HCSP-5. The results are shown in Figure 4 . In both cases a single DNA fragment of the expected size (338 bp or 422 bp respectively) was amplified. The presence of potentially contaminating genomic DNA was excluded as no product was obtained in any case if the reverse transcription step was omitted (control lanes). As a final control, we did the PCR experiment using a sense primer (HCSP-1) which hybridizes to the genomic sequences upstream to the transcription start site. This experiment did not give any product in PCR amplifications (Figure 4 ). The sequence of the 338 bp and the 422 bp PCR fragments derived from mRNA revealed that they were identical with the sequences obtained from the genomic clone. Thus the results of the primer extension/RT-PCR experiment together with the sequence information from mRNA confirm that the 5' untranslated sequences for the human cytochrome b561 are not derived from intron sequences.
The 3' untranslated region of human cytochrome b561 mRNA is 1500 bases in length. A consensus sequence for polyadenylation is found at position 2633. This is shown in Figure 1 . A comparison of the 3' untranslated region of the human cDNA to the corresponding segment of the bovine cDNA revealed that most of the sequences had no similarity except for the 130 bp segment of the human cDNA (bp 1618-1748) which is approx. 820% identical with the bovine cDNA (bp 1314-1440). This aligned comparison is shown in Figure 2( immunoreactive band migrating at an approximate molecular mass of 28 kDa was observed ( Figure 5, lane 3) . The presence of cytochrome b561 in lung is not surprising in view of the fact that the small granule cells in this tissue contain catecholamine secretory vesicles (Sorokin and Hoyt, 1989) , although a larger amount of membrane fraction was needed for the detection of cytochrome b561 compared with chromaffin granule membranes.
A comparison of the amino acid sequences of the human and bovine proteins is shown in Figure 6 . The sequences are 86 % identical. The human sequence has a residue between positions 8 and 9 of the bovine protein, however, the rest of the sequence is in frame. We have previously postulated that the histidines 109 and 182 of the bovine protein are important for haem binding (Fleming and Kent, 1991) . The conservation of these histidine residues in both species supports our hypothesis ( Figure 6 ).
Tissue distribution of cytochrome bh51 expression As it has been proposed that cytochrome b561 may be a marker for neuroendocrine secretory vesicles, Northern-blot analysis was performed to determine the expression of the mRNA in various human tissues. The results of the duplicate experiment are shown in Figure 7 . A major band at approx. 3300 bp was The deduced amino acid sequence of the human cytochrome b561 is shown as a continuous sequence. In those positions where the bovine sequence differs, the alternative bovine residue is indicated by the one letter code below the human sequence. Residues proposed to be part of a haem-binding pocket (Fleming and Kent, 1991) (Brass et al., 1989) . A surprising result was the high level of cytochrome mRNA in placenta and pancreas as peptidyl a-amidating monooxygenase mRNA levels are very low in this tissue in the rat (Brass et al., 1989) . These results suggest that it would be worthwhile to investigate the level of dopamine ,J-hydroxylase mRNA in placenta and pancreas. 
DISCUSSION
The apocytochrome N-terminus begins with the amino acid sequence MEG for human cytochrome b561. This sequence corresponds to the second translation initiation site in the bovine cDNA. Analysis of the sequence context of both first and second ATG revealed that the second bovine translation initiation site agrees more closely with the consensus sequence for initiator methionines than does the first translation initiation site (Perin et al., 1988) . Western-blot analysis of human lung reveals an immunoreactive band migrating at an apparent molecular mass similar to that found in bovine chromaffin granules. This apparent molecular mass of the bovine cytochrome is most consistent with the second translation initiation site being used. Also, a Xenopus clone sequenced at the 5'-end starts with the second translation initiation of the bovine and has a stop codon five amino acids upstream of the ATG (M. Srivastava, unpublished work). Taken together with the results on human cytochrome b561 presented here, these results suggest that bovine apocytochrome is 22 amino acid residues shorter than previously proposed (Perin et al., 1988) . Because the N-terminus of bovine cytochrome b561 cannot be experimentally detected on the cytoplasmic side, sequence from both the human and bovine cytochrome of similar size were compared and critically analysed in an attempt to create a structural model in which the N-terminus would be located internal to the granule. The most N-terminal membrane-spanning segments were analysed according to the method of Hartman et al. (1989) . Importantly, the amino acid sequence in the human cytochrome N-terminal from the first hydrophobic segment has a net charge of zero. Therefore, an Nexo.-Cyt. (N-terminus towards the matrix side and C-terminus towards the cytoplasmic side) orientation ofthe first hydrophobic transmembrane segment is possible according to correlative and experimental results on other signal/anchor segments (Hartman et al., 1989; Parks and Lamb, 1991) . Such an orientation would explain the inability of both antibodies and Pronase to interact with the N-terminal region of cytochrome in intact chromaffin granules (Kent and Fleming, 1990 ).
An Nexo-Ccyt orientation of the first hydrophobic transmembrane segment in cytochrome b561 would require an odd number of transmembrane segments because the C-terminus faces the cytoplasm (Kent and Fleming, 1990) . In fact, the second putative transmembrane segment in the original model (Perin et al., 1988) does not meet the conservative criteria for hydrophobicity of transmembrane segments defined by von Heijne (von Heijne and Gravel, 1988) (i.e. a mean 19-residue hydrophobicity > 1.5 on the Engelman-Steitz scale). Furthermore this segment, for both the human and bovine cytochromes, contains several amino acid residues (C, D, N and Q) which have very low abundance in eukaryotic transmembrane segments (von Heijne and Gavel, 1988) .
Considering the experimental data on haem content and topological accessibility, together with the predictive criteria on hydrophobic transmembrane segments with low hydrophobicity and the unusual amino acid composition of segment two, a likely model for human cytochrome b561 is shown in Figure 8 . In contrast with previous models ofthe cytochrome, this cytochrome contains five hydrophobic transmembrane segments, an NexoCCYt orientation of the first transmembrane segment and a single haem-binding pocket. These three characteristics are more in agreement with the experimental evidence than previous models based on the bovine sequence. The model also leads to the testable hypothesis that antibodies to the first cytoplasmic loop (Arg-39-Lys-84) should interact with the cytochrome in intact chromaffin granules.
The expression of cytochrome b561 appears to be constitutive when compared with other secretory vesicle protein components which are under hormonal and neuroendocrine regulation (Winkler et al., 1990 ). The cytochrome also shows distinct tissuespecific expression. This has led to the hypothesis that cytochrome b561 would be a basic feature of all peptidergic and adrenergic tissues. In mammals other than humans, immunological studies have shown that it is present in splenic-nerve terminals and posterior and anterior hypophysis (Hortnagle et al., 1973) ; in many areas of the brain ; in blood vessels, retina, enteric-nerve fibres, and atrial heart (Pruss and Shepard, 1987) ; and in thyroid parafollicular cells (Weiler et al., 1989) . Curiously no cross-reacting material was observed in bovine pancreas or kidney where it would be expected to participate in the formation of amidated neuroendocrine peptides (Brass et al., 1989) . RNA blotting experiments have shown a similar distribution in bovine tissues except that no hybridization was seen in heart ventricles and the data are not available for placenta, pancreas or kidney (Perin et al., 1988) .
The expression of cytochrome has not been characterized in humans. The RNA hybridization results reported here show that cytochrome mRNA is also expressed in pancreas and kidney; two tissues which previously did not appear to contain cyto- We thank Dr. T. Sudolf for a cDNA clone (pcyt6a) of the bovine cytochrome and Dr. A. Lee Burns for helpful discussions.
